Glycemic control and health care costs for patients with diabetes [3] (multiple letters)

Journal of the American Medical Association

Volumn 285, Issue 15, 2001, Pages 1963-1964

  Pogach, Len ^a   Wagner, Ed H ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Costs and cost analysis; Depression; Diabetes mellitus; Drug reaction, Adverse; Health care costs; Hyperglycemia

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN;

COMORBIDITY; COST CONTROL; DIABETES MELLITUS; DOCTOR PATIENT RELATION; DRUG UTILIZATION; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH MAINTENANCE ORGANIZATION; HUMAN; LETTER; LIFESTYLE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0035906305     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.15.1963     Document Type: Letter

References (5)

1. Effect of improved glycemic control on health care costs and utilization
2. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes: A randomized, controlled clinical trial
3. Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs
4. Do individuals with subtance abuse diagnoses incur higher charges than individuals with other chronic conditions?
5. The national depressive and manic depressive association concensus statement on the undertreatment of depression